Correlation Between Prime Medicine, and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine, Common and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Prime Medicine, and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and Vertex Pharmaceuticals.
Diversification Opportunities for Prime Medicine, and Vertex Pharmaceuticals
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Prime and Vertex is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Prime Medicine, and Vertex Pharmaceuticals
Given the investment horizon of 90 days Prime Medicine, is expected to generate 1.15 times less return on investment than Vertex Pharmaceuticals. In addition to that, Prime Medicine, is 3.72 times more volatile than Vertex Pharmaceuticals. It trades about 0.06 of its total potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.26 per unit of volatility. If you would invest 39,664 in Vertex Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of 2,536 from holding Vertex Pharmaceuticals or generate 6.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Prime Medicine, Common vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Prime Medicine, Common |
| Vertex Pharmaceuticals |
Prime Medicine, and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prime Medicine, and Vertex Pharmaceuticals
The main advantage of trading using opposite Prime Medicine, and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |